BABodil Andersson

Bodil Andersson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bodil Andersson has a total of 730 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intravenous Lidocaine in Liver Surgery ‒ A Randomized Double-Blind Trial

    by Emil Östrand, Jenny Rystedt, Ingrid Östlund, Thomas Kander, Bodil Andersson, Bobby Tingstedt

    Background: Managing postoperative pain is a complex challenge in liver surgery. Perioperative intravenous (IV) lidocaine can reduce postoperative pain, opioid use, bowel recovery time and the length of stay, in various types of surgery. Lidocaine is eliminated via hepatic metabolism, and IV lidocaine is rarely evaluated in liver surgery. This study aimed to evaluate the postoperative analgesic efficacy and safety of IV lidocaine administration in patients undergoing minor liver surgery. Methods: Patients planned for minor liver surgery were randomized 1:1 to receive either perioperative IV lidocaine, administered as a 1.5 mg/kg bolus followed by a continuous infusion of 1.5 mg/kg/h until 1 hour after surgery, or placebo. All patients received postoperative opioid analgesia via a patient-controlled analgesia device. The primary outcome was postoperative opioid consumption during the first 24 hours after surgery. Secondary outcomes included postoperative pain scores, quality of recovery, adverse events, length of stay, and plasma lidocaine concentrations. Results: In total, 124 subjects were included. Postoperative opioid consumption during the first 24 hours after surgery was 83 (50 – 129) mg oral morphine equivalents (OME) in the lidocaine group, and 97 (60 – 135) mg OME in the placebo group, p=0.429. Patients in the lidocaine group experienced lower pain scores at early postoperative time points, but not from postoperative day 1 onward. The Quality of recovery-40 score did not differ, and adverse events were similar between groups. In two cases, plasma concentrations of lidocaine were transiently above 5 µg/ml after bolus administration, without clinical signs of toxicity. All plasma concentrations after resection and at end of infusion were safely below toxic levels. Conclusions: Perioperative intravenous lidocaine did not reduce postoperative opioid consumption after minor liver surgery but conferred transient early analgesic benefits and was found to be safe.

  • Open Access

    International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot

    by Chiara D'ALterio, Quirino Lai, Maria Lanzone, Roberto Valente, Matteo Fabbrici da Correggio, Immacolata Iannone, Alessandro Coppola, Salah Berkane, Tomas Koltai, Lucas McCormack, et al.

  • Open Access

    New-onset diabetes after distal pancreatectomy–findings from a national cohort study

    by Henrik Bergenfeldt, Katarina Fagher, Caroline Williamsson, Bodil Andersson

    Henrik Bergenfeldt, Katarina Fagher, Caroline Williamsson, Bodil Andersson. Ann Hepatobiliary Pancreat Surg 2026;30:367-73. https://doi.org/10.14701/ahbps.26-100

  • Open Access

    Survival After Pancreatic Resection for Intraductal Papillary Mucinous Neoplasm: Supporting Selective Surgery

    by Marcus Holmberg, Tomaso Dall'OLio, Mohamed Marwa, Carsten Palnaes Hansen, Dyre Berg Kleive, Gennaro Nappo, Lam Shi, Per Sandström, Dennis Björk, Parsa Hadesi, et al.

    Introduction: Resection of intraductal papillary mucinous neoplasm (IPMN) aims to prevent progression to invasive pancreatic cancer. However, the risks of pancreatic surgery and frequent findings of low‐grade dysplasia (LGD) raise concerns about overtreatment. This EAHPBA‐endorsed multinational study evaluated short‐ and long‐term overall survival (OS) following preventive resection for IPMN (without pre‐operative signs of cancer). Methods: Adult patients with resected IPMN showing LGD, high grade dysplasia (HGD) or T1‐staged invasive carcinoma from 2008–2023 were identified from the OPTIMAL‐IPMN database. Estimated OS rates at one, five and 10 years in patients undergoing preventive pancreatic resection were assessed using Kaplan‐Meier analyses and predictors for mortality were evaluated using parametric survival regressions. Results: Among 2275 patients in the OPTIMAL‐IPMN database, 1728 (77%) had undergone preventive pancreatic resection for IPMN. Of those were 61% resected without prior surveillance. Final pathology revealed LGD in 63%, HGD in 27% and T1a‐c‐staged invasive cancer in 10% (7.3% T1a‐b, 2.8% T1c). Estimated 1‐year OS rate was 97%. Estimated 5‐year OS rates (landmark analysis at 1 year) for LGD, HGD, T1a‐b, and T1c was 97%, 99%, 96% and 91% respectively. Independent predictors for long‐term mortality included age ≥ 75 versus < 75 years (HR 1.97) and T1c versus LGD (HR 8.12). Conclusion: This multinational study confirms excellent survival after preventive IPMN resection but reveals many upfront resections yielding LGD with unknown survival benefit. Future studies should aim to determine which patients can be followed safely with monitoring to avoid unnecessary immediate resection.


  • Open Access

    Real-world management of intraductal papillary mucinous neoplasms – findings from a nationwide survey

    by Bodil Andersson, Poya Ghorbani, Mikael Öman, Bergthor Björnsson, Johanna Wennerblom Hansson, Robert Szepesvari, Muhammed Al-Jubouri, Johan Nilsson, Caroline Williamsson

    Intraductal Papillary Mucinous Neoplasm (IPMN) is a mucin-secreting epithelial neoplasm that arises in the main pancreatic duct (MD), its branch ducts (BD) or both (mixed-type [MT]). The developmen...

  • Top Cited Papers
    Open Access

    Oncologic multivisceral resections involving the pancreas: Short-term outcomes and risk-analysis

    by Artur Rebelo, Bodil Andersson, Samik Kumar Bandyopadhyay, Paulina Bereza-Carlson, Frederik Berrevoet, Bergthor Björnsson, Stefan Bouwense, Florian Bösch, Markus Büchler, Nikolaos Chatzizacharias, et al.

    Objective: To evaluate short-term outcomes and identify predictors of morbidity and mortality following multivisceral oncologic resections involving the pancreas. Summary background data: Multivisceral resections including the pancreas are required for locally advanced abdominal malignancies but are associated with considerable perioperative risk. While smaller series suggest acceptable outcomes in selected patients, large-scale international data are lacking to guide surgical decision-making and risk stratification. Methods: This was a retrospective cohort study of 1283 patients from 31 international centers who underwent multivisceral oncologic resections involving the pancreas. Patient demographics, tumor characteristics, operative details, and 90-day postoperative outcomes were analyzed. Results: The cohort had a mean age of 64.7 years, and 54.7% were male. Distal pancreatectomy was the most frequent procedure (60.5%), and R0 resection was achieved in 60.9% of cases. The 90-day mortality was 6.9%, highest in patients with gastric adenocarcinoma (16.7%). Major complications (Clavien–Dindo grade III–V) occurred in 34.4% of patients. Higher ASA classification and open surgical approach were independently associated with increased morbidity and mortality. Prolonged operative time was associated with morbidity only. Female gender and treatment at high-volume centers were protective. In patients with pancreatic tumors, resection involving the colon (OR: 1.78, P < 0.001), stomach (OR: 1.33, P = 0.042), or three or more organs (OR: 1.75, P = 0.006) significantly increased complication rates. Conclusions: Multivisceral resections involving the pancreas are associated with relevant perioperative risk. Optimizing patient selection, favoring minimally invasive techniques when feasible in selected patients, and centralizing care to high-volume centers may help improve outcomes for these complex surgical procedures.


  • Open Access

    Incidence, Risk Factors, and Time Trends for Bile Leakage After Cholecystectomy for Gallstone Disease—Results From a Population‐Based Cohort Study

    by Layla Mirzaei, Henrik Bergenfeldt, Stefan Öberg, Bodil Andersson

    Background: Bile leakage is a severe complication after cholecystectomy and is associated with an increased risk of morbidity and mortality. The aim of this study was to evaluate the incidence of bile leakage post‐cholecystectomy and to identify potential risk factors and their association with changes in the incidence of bile leakage over time. Methods: Demographic and perioperative data of all patients who underwent cholecystectomy in Sweden between 2006 and 2019 were retrieved from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks). Data on the occurrence of bile leakage within 30 days were recorded and risk factors were identified using uni‐ and multivariable logistic regression analyses. Results: Bile leakage occurred in 1738 of the 152,413 patients who underwent cholecystectomy, resulting in an overall incidence of 1.14%. The incidence was relatively consistent over the study period. ASA‐score II and III, emergent surgery, open cholecystectomy, conversion from laparoscopic to open technique, bleeding requiring intervention, not performing, or incomplete intraoperative cholangiography (IOC) were identified as risk factors for bile leakage. The proportion of ASA II and ASA III patients undergoing cholecystectomy increased over time ( p < 0.001). There was also a significant increase in the proportions of emergent cholecystectomies from 27.9% to 43.6% ( p < 0.001) and surgery for complicated gallstone disease from 35.4% to 52.5% ( p < 0.001) during the study period. Conclusion: The incidence of bile leakage was relatively consistent over the study period despite an observed increase in the prevalence of identified risk factors of bile leakage.


  • Open Access

    Nationwide implementation of minimally invasive liver surgery: population-based analysis

    by Emil Östrand, Jenny Rystedt, Bobby Tingstedt, Bodil Andersson

    Background: Previous studies of minimally invasive liver surgery described results and experiences in high-volume centres and early adopters, but data on national levels are lacking. This study evaluated the implementation and outcomes of minimally invasive liver surgery in Sweden over a 15-year period, with a focus on colorectal liver metastases. Methods: Data from patients undergoing liver surgery between 2009 and 2023 were obtained from the Swedish National Quality Registry for Liver, Gallbladder and Bile Duct Cancer, and evaluated in time intervals. Propensity score matching analysis was used to compare outcomes between open and minimally invasive liver surgery for colorectal liver metastases. Results: A total of 9977 procedures were included in the study, of which 1490 (14.9%) were minimally invasive. Minimally invasive liver surgery was used increasingly over time, and had better short-term outcomes than open liver operations, including less blood loss (median 200 (interquartile range 50–400) versus 500 (250–1000) ml; P < 0.001), fewer major complications (127 (9.3%) versus 1697 (21.9%); P < 0.001), and a lower 30-day mortality rate (6 patients (0.4%) versus 107 (1.3%); P = 0.004). Use of robotically assisted liver surgery increased over time and it constituted 311 minimally invasive liver procedures (38.4%) in the late time period. Propensity score matching analysis for patients with colorectal liver metastases showed reduced blood loss with minimally invasive liver surgery (P < 0.001), a similar rate of radical resections, and similar overall survival. Conclusion: The study demonstrated safe nationwide implementation of minimally invasive liver surgery. Use of the minimally invasive approach increased over time, including a rapid rise for robotically assisted procedures in the later period. Minimally invasive liver surgery maintained or improved favourable short-term outcomes without adverse effects on morbidity, mortality or long-term survival after surgery for colorectal liver metastases.

  • Open Access

    The effect of diabetes on complications after distal pancreatectomy: A population-based cross-matched registry study

    by Henrik Bergenfeldt, Eva Ekström, Katarina Fagher, Karin Filipsson, Bodil Andersson

    Background: Distal pancreatic resection is associated with a high frequency of postoperative complications. The aim of this study was to characterize the effect of diabetes mellitus (DM) on short-term complications after distal pancreatectomy. Methods: Patients who underwent distal pancreatectomy between 1 January 2010 and 31 December 2020 were identified from the Swedish National Pancreatic and Periampullary Cancer Registry, and the data were cross-linked with the National Diabetes Registry. The complication rates were compared between patients with and without diabetes. Results: In total, 1297 patients underwent distal pancreatectomy, and 247 (19%) of these patients had DM. Postoperative complications occurred in 697/1297 (54%) patients. There was no difference observed in the risk of overall complications (odds ratio (OR) = 0.76, 95% confidence interval [CI]: 0.58–1.00; p = 0.052), general surgical complications (p = 0.053), medical complications (p = 0.872), or postoperative pancreatic fistula rates (p = 0.603) according to the univariable analysis. In the multivariable analysis, patients with DM demonstrated a lower risk of overall complications (OR = 0.72, 95% CI = 0.54–0.96; p = 0.025). In the subgroup analysis, patients with high mean HbA 1c levels (p = 0.041), high last measurement (p = 0.032), or DM duration >10 years (p = 0.022) exhibited lower risks of complications in the multivariable analysis. Conclusion: This study revealed a lower overall complication risk in patients with DM compared to patients without DM after distal pancreatectomy; however, no difference in the pancreatic fistula rate or medical complications was observed.


  • Open Access

    The impact of gallstone intervention during pregnancy on maternal and perinatal outcomes: a nationwide population-based cohort study

    by Bodil Andersson, Jonas Hedström, Dag Wide-Swensson, Johan Nilsson

    Gallstone disease during pregnancy can have varying consequences, from mild to severe and even life-threatening. The aim was to investigate how gallstone intervention during pregnancy impacts pregnancy, delivery and the newborn child. Pregnant patients 18-45 years identified from the Swedish National Register for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks) 2009-2016 constituted the intervention group and were cross-linked with the Swedish National Medical Birth Register. A 1:5 matched control group of patients without gallstone intervention during pregnancy was established. In total, 1620 women were included, and of these, 274 underwent gallstone intervention during pregnancy. Some 221 women underwent cholecystectomy only, and 53 underwent ERCP only or combined with cholecystectomy. The women in the intervention group had a higher BMI at the start of pregnancy (24 vs 28, p < .001) and were more often smokers (21.7% vs. 15.7%, p = .019). Overall, labour started most often spontaneously, (intervention group 67.0% vs. control group 75.3%, p = .004), and elective caesarean section was more common in the intervention group (13.2 vs. 9.0%, p = .034). Premature birth was more common in the intervention group (19 [6.93%] vs. 5 [3.94%], p = .029), with an adjusted odds ratio of 1.8 (CI 1.1-3.3, p < .001). There were no differences in the children's birth weights or APGAR scores. Caesarean section was more common, and the duration of pregnancy was shorter, including preterm births, in the group with gallstone intervention during pregnancy. However, for the newborn child, birth weight corrected for gestational age and APGAR score was not affected.